Evidence map›Paper›PMID 38258816›Full record

ArticleSubstance use & addiction journal2024

Providers' Experiences and Perspectives in Treating Patients With Co-Occurring Opioid and Stimulant Use Disorders in the Hospital.

Riley D Shearer, Edith Hernandez, Timothy J Beebe, Beth A Virnig, Gavin Bart, Tyler N A Winkelman, Angela R Bazzi, Nathan D Shippee

Open access · greenAbstract read
In one paragraph

Article in Substance use & addiction journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Riley D ShearerDivision of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN, USA.ORCID 0000-0003-0100-8613
Edith HernandezDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, USA.
Timothy J BeebeDivision of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN, USA.
Beth A VirnigCollege of Public Health and Health Professions, University of Florida, Gainsville, FL, USA.
Gavin BartDivision of Addiction Medicine, Department of Medicine, Hennepin Healthcare, Minneapolis, MN, USA.
Tyler N A WinkelmanHealth, Homelessness, and Criminal Justice Lab, Hennepin Healthcare Research Institute, Minneapolis, MN, USA.
Angela R BazziHerbert Wertheim School of Public Health, University of California San Diego, La Jolla, CA, USA.
Nathan D ShippeeDivision of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN, USA.
University of Minnesota · USHennepin Healthcare Research Institute · USUniversity of California San Diego · USUniversity of Florida · USUniversity of Minnesota Medical Center · US

Funding

Suicide Prediction and Prevention for People at Risk for Opioid Use DisorderUG1DA040316 · NIDA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI GAVIN BART · 2015 to 2026
$42.2M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008244 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SHIMIZU, YOJI · 1988 to 2024
$13.6M
UMB Postbaccalaureate Research Education ProgramR25GM113262 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI ANTALIS, TONI M, CAREY, GREGORY B · 2016 to 2025
$3.2M
Characteristics and outcomes for hospitalized patients with methamphetamine and opioid co-use: Identifying opportunities for hospital-based addiction services tailored to co-useF30DA057775 · NIDA · UNIVERSITY OF MINNESOTA · PI Riley Shearer · 2023 to 2026
$171k
NIDA NIH HHS F30 DA057775NIDA NIH HHS UG1 DA040316NIGMS NIH HHS R25 GM113262NIGMS NIH HHS T32 GM008244
6 · The paper itself

Abstract

backgroundThe overdose crisis is increasingly characterized by opioid and stimulant co-use. Despite effective pharmacologic treatment for both opioid use disorder (OUD) and contingency management for stimulant use disorders, most individuals with these co-occurring conditions are not engaged in treatment. Hospitalization is an important opportunity to engage patients and initiate treatment, however existing hospital addiction care is not tailored for patients with co-use and may not meet the needs of this population.

methodsSemi-structured interviews were conducted with hospital providers about their experiences and perspectives treating patients with opioid and stimulant co-use. We used directed content analysis to identify common experiences and opportunities to improve hospital-based treatment for patients with co-use.

resultsFrom qualitative interviews with 20 providers, we identified 4 themes describing how co-use complicated hospital-based substance use treatment: (1) patients' unstable circumstances impacting the treatment plan, (2) co-occurring withdrawals are difficult to identify and treat, (3) providers holding more stigmatizing views of patients with co-use, and (4) stimulant use is often "ignored" in the treatment plans. Participants also described a range of potential opportunities to improve hospital-based treatment of co-use that fall into 3 categories: (1) provider practice changes, (2) healthcare system changes, and (3) development and validation of clinical tools and treatment approaches.

conclusionsWe identified unique challenges providing hospital addiction medicine care to patients who use both opioids and stimulants. These findings inform the development, implementation, and testing of hospital-based interventions for patients with co-use.

Indexed as

Drug OverdoseOpioid-Related DisordersAnalgesics, OpioidDelivery of Health CareHospitalsHumansAnalgesics, Opioidhospital addiction medicineopioidspolysubstance usestimulants

Identifiers

PMID38258816
PMCPMC11151687
OpenAlexW4390754033

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.